PureTech Health (GB:PRTC) has released an update.
PureTech Health’s Seaport Therapeutics has appointed Lauren White as Chief Financial Officer. With her extensive experience in biotech finance, including her pivotal role in ImmunoGen’s $10.1 billion acquisition by AbbVie, White is set to enhance Seaport’s financial strategies. Her leadership is expected to drive the company’s mission to deliver innovative neuropsychiatric medicines.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
